首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2866篇
  免费   0篇
化学工业   23篇
金属工艺   4篇
机械仪表   4篇
建筑科学   7篇
能源动力   2篇
轻工业   36篇
石油天然气   2篇
无线电   13篇
一般工业技术   30篇
冶金工业   2723篇
原子能技术   1篇
自动化技术   21篇
  2019年   2篇
  2013年   15篇
  2012年   4篇
  2011年   2篇
  2010年   1篇
  2009年   3篇
  2008年   4篇
  2007年   2篇
  2006年   3篇
  2005年   7篇
  2004年   9篇
  2003年   9篇
  2002年   1篇
  2001年   3篇
  2000年   4篇
  1999年   85篇
  1998年   829篇
  1997年   480篇
  1996年   308篇
  1995年   172篇
  1994年   138篇
  1993年   178篇
  1992年   34篇
  1991年   41篇
  1990年   27篇
  1989年   34篇
  1988年   50篇
  1987年   34篇
  1986年   34篇
  1985年   28篇
  1984年   5篇
  1983年   4篇
  1982年   14篇
  1981年   18篇
  1980年   24篇
  1979年   7篇
  1978年   6篇
  1977年   53篇
  1976年   158篇
  1975年   10篇
  1974年   2篇
  1973年   2篇
  1972年   2篇
  1971年   2篇
  1969年   3篇
  1968年   1篇
  1967年   5篇
  1966年   2篇
  1957年   2篇
  1955年   3篇
排序方式: 共有2866条查询结果,搜索用时 15 毫秒
101.
In situ oxidation of Ni-30Cr and TDNiCr (Ni20wt %Cr2 vol. %ThO2) in the high voltage electron microscope has been used to examine the early stages of oxidation over the temperature range ~ 450–700°C in 15 Torr O2. Companion studies on thin foils and bulk specimens oxidized out of the microscope gave results similar to the in situ studies, indicating that the in situ results reveal true oxidation behavior. A notable feature was the observation that oxide nucleation and growth occurred on a variety of interfaces, such as grain boundaries, large inclusions, and slip bands. The growth of grain boundary oxides was studied, and a mechanism is proposed to account for the kinetics.  相似文献   
102.
103.
Flaujeac trait is the functional deficiency of a plasma protein of the intrinsic coagulation, kinin-forming, and plasma fibrinolytic pathways. The Flaujeac factor in man has been isolated and tentatively identified as a kininogen of high molecular weight (HMW). Highly purified bovine HMW-kininogen, but not bovine low molecular weight kininogen, repaired Flaujeac factor deficiency. The two subspecies of this molecule, HMW-kininogen a and HMW-kininogen b, also corrected Flaujeac factor deficiency. When bovine HMW-kininogen was incubated with bovine plasma kallikrein, kinin-free HMW-kininogen, bradykinin, and a glycopeptide fragment (peptide 1-2; 12,584 daltons) were rapidly released. None of these fragmentation products corrected Flaujeac factor deficiency alone or in mixtures. The function of HMW-kininogen appeared to depend upon the structural integrity of the native molecule. When injected in concentrations of 2 pmol-8 nmol/0.1 ml, peptide 1-2 caused increased vascular permeability in rabbits, rats, or guinea pigs. The enhanced permeability was maximal within 1-2 min and terminated in 5-10 min, differing from that of bradykinin or histamine. Injected together in equimolar amounts, peptide 1-2 and bradykinin produced a synergistic permeability response which was immediate in onset as well as prolonged in duration. Peptide 1-2 is a rapidly acting, highly basic glyco-peptide which mediates increased vascular permeability in a complementary and synergistic manner with bradykinin.  相似文献   
104.
105.
Intrauterine fetal demise is a source of anxiety to both patient and physician. Heretofore, the standard treatment was either careful observation until the patient went into labor or attempt at induction of labor with oxytocin. Unfortunately, oxytocin stimulation has not proven to be uniformly successful for this problem. Prostaglandin E2 suppositories have been shown to be effective in inducing uterine evacuation after intrauterine fetal demise. In the opinion of the authors, this approach will in the future replace the sometimes dangerous and emotionally laden convention of watchful delayed therapy.  相似文献   
106.
Conscious sheep with permanent indwelling cannulae in the lateral ventricles and the cisterna magna were Na depleted and then perfused for 9 h with an artificial CSF solution. There were 3 experimental groups: Group I (n=5) received perfusion with aritifical CSF containing NA 170 MEq./1, Group II (n=7) received perfusion with artificial CSF containing Na 145 mEq./1, Group III (n=7) received no perfusion. In Group I the blood aldosterone level fell from 26.4 +/- 7.4 to 8.6 +/- 2.3 ng/100 ml by 9 h after perfusion. There was no significant change in plasma [Na] or [K], blood angiotensin II or plasma renin concentration. Blood cortisol and corticosterone levels rose. There was also a fall in post-perfusion. Group III showed no significant change in blood aldosterone concentration. Multivariate statistical analysis showed that the fall in aldosterone levels during 170 mEq./l Na perfusion could not be accounted for by changes, either alone or together, of ACTH as evidenced by alteration in blood cortisol or corticosterone, or by change of plasma [Na], [K] or renin concentrations. This data supports the hypothesis of an additional factor which may be of CNS origin being involved in the control of aldosterone secretion.  相似文献   
107.
Thermodynamic analyses based on the concepts of irreversible entropy increases or exergy losses have frequently been suggested as pointers to sources on inefficiency in chemical processes. For instance, by evaluating the entropy gain in distillation systems, an incentive might be identified for research into thermodynamically more effient separation technology.

However, a process engineer seeking to design a practical flowsheet with present day technology is much less certain about the value of thermodynamic analysis. In his environment of technical constraints, the interpretation of thermodynamic criteria is by no means straightforward and may even lead to incorrect conclusions unless some care is taken.

The present paper describes an approach overcoming this problem. Examples are quoted from the studies of two industrial processes (Sulphuric acid and nitric acid). Further, a generalised discussion is given and results are quoted from the successful application of the approach in fourteen ICI design projects.  相似文献   

108.
109.
110.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号